Joining the discussion is Dr. Paul Ridker, a leading expert from Harvard known for his innovations in cardiovascular inflammation. He sheds light on how inflammatory markers like hs-CRP are crucial for assessing cardiovascular risk. The conversation highlights insights from groundbreaking studies, including JUPITER and CANTOS, which paved the way for new treatment strategies. Dr. Ridker also explores the connection between autoimmune disorders and cardiovascular health, emphasizing the importance of targeted anti-inflammatory therapies for risk reduction.